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Summary: The mechanism of the observed decrease in the plasma concentra- 
tion of several amino acids in the presence of high levels of Leu has remained 
unexplained. In the present study a decrease in the plasma concentration of Ile, 
Val, Phe, Tyr, Met, Ala, Pro and Gly was observed after the intraperitoneal 
injection of Leu to weanling rats. Decreases in net intracellular concentrations 
in muscle accompanied the decrease in plasma of all of these amino acids except 
Pro and Gly. An increase in the distribution ratio muscle/plasma was observed 
exclusively for Gly after administration of Leu or of a non-insulinogenic 
transport system L analogue. Diazoxide suppressed the Leu-induced decreases 
in plasma and muscle intracellular concentrations of Ile and Val as well as of 
Pro in plasma. An increase in the distribution ratio liver/plasma was observed 
for Pro and Gly in the absence but not in the presence of diazoxide. All the 
above changes were statistically significant. Hence insulin probably mediates 
Leu effects, promoting an increased utilization of lie and Val in muscle and of 
Pro in liver. A more direct effect of Leu appears to be involved in the apparent 
increased utilization of Phe, Tyr and Ala in the same tissue. Gly depletion in 
plasma can be explained by its trapping by inhibitory action of Leu on the 
exodus of Gly through transport system L. 
High levels of Leu are usually accompanied by a decrease in the plasma concentrations 
of several amino acids. In maple syrup urine disease (McKusick 24860) (MSUD) lie 
and Val are often decreased in plasma in the presence of high Leu levels, in spite of 
a common metabolic block affecting the catabolism of the three branched-chain 
amino acids (BCAA) (DiGeorge et al., 1982; Snyderman et al., 1964). Experimental 
administration of Leu results also in a decrease of Ile and Val, but other, mainly the 
bulky neutral amino acids also known as large neutral amino acids (LNAA), are also 
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depleted in plasma. This effect has been observed in rats fed high-Leu diets (Rogers 
et al., 1962), after oral loads of Leu to children, either normal or with MSUD (Nyhan 
et al., 1961; Snyderman et aI., 1984), as well as after intravenous Leu infusion to 
healthy adults (Eriksson et aL, 1981) or to patients with hepatic encephalopathy 
(Rossi-Fanelli et al., 1986). In the latter, the Leu-induced decreases in the plasma 
concentrations of Phe and Tyr apparently result in clinical improvement (Rossi- 
Fanelli et  al., 1986). 
The mechanisms of these decreases have, however, not been explained. Loss in the 
urine has been excluded as a cause (Nyhan et aI., 1961). Indeed, it is likely that 
different mechanisms may apply to different amino acids or groups of amino acids. 
Leu is a well-known insulin secretagogue both in humans (Fajans et aL, 1967) and 
rats (Landgraf et al., 1974), and insulin has long been known to cause a decrease in 
the concentrations of various amino acids in plasma (Luck et al., 1928), the BCAA 
being the most sensitive (Fukagawa et al., 1986). Transport effects have been proposed 
but not demonstrated (Nyhan et al., 1961; Eriksson et al., 1981). Eriksson et al. (1981) 
have suggested that exchange diffusion, a distinctive property of transport system L 
(Oxender and Christensen, 1963; Winter and Christensen, 1964), between high 
intracellular Leu and plasma LNAA may be involved. Previous work in this 
laboratory has shown, furthermore, that system L in muscle (Christensen et al., 1948) 
and liver (Christensen and Cullen, 1981) apparently serves extensively for exodus of 
several neutral amino acids, previously concentrated into the cell by Na÷-dependent 
transport systems (Oxender and Christensen, 1963) that operate mainly inwards in 
these tissues. One of us (H.N.C.) has proposed that this effect may explain the ability 
of Leu to decrease the neutral amino acids in plasma (Christensen, 1987). In fact, we 
have shown recently that this inhibitory mechanism applies for various small neutral 
amino acids, explaining for this group a similar decreasing effect of the Phe on their 
plasma levels (de Crspedes et al., 1989). 
The aim of the present study was to test this hypothesis as well as to assess the 
role of insulin in the aforementioned effect of Leu on other plasma amino acids. 
EXPERIMENTAL PROCEDURES 
Materials:  L-Leucine was obtained from Sigma Chemical Co. The racemic aminoexo 
isomer of the 2-aminonorbornane-2-carboxylic acid, aminoexo-2-aminobicyclo- 
(2,2,1)heptane-2-carboxylic acid, often designated as a(_)BCH, but abbreviated here 
as aBCH, was our own preparation (Tager and Christensen, 1972). A commercial 
preparation of diazoxide (Hyperstat IV, Schering Corp.) was used. All other reagents 
were of the best grade commercially available. 
Animals: Twenty two-day-old Sprague-Dawley male weanling rats weighing 38- 
66 g were used for all the experiments. Rats were fasted for 20-24h before each 
experiment. 
Procedure: Leu or aBCH was injected intraperitoneally as an isotonic solution at 
a dose of 10 mmol/kg body weight. Control rats received an intraperitoneal injection 
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of 0.85% NaC1 (w/v) in the corresponding volumen. Diazoxide was also injected 
intraperitoneally, at a dose of 200 mg/kg body weight 15 min before Leu; control rats 
received an intraperitoneal injection of distilled water in the corresponding volumen 
(in no case higher than 0.7 ml). 
Two hours after the Leu or aBCH injection the rats were anaesthetized with ether. 
Blood was taken from the exposed heart and collected in a heparinized tube. Plasma 
was separated and deproteinized with an equal volumen of 12% sulphosalicylic acid. 
Approximately 1 g of liver and 0.5 g of muscle from the left thigh were weighed and 
ground in a mortar containing sand and a 10% solution of sulphosalicylic acid at a 
volume 4 times the fresh weight of the tissue in grams. The homogenate was filtered 
through Whatman No. t paper. The protein-free filtrate was stored at -20°C until 
analysis. 
Analysis: Amino acids were measured with a model 119 CL Beckman automatic 
amino acid analyser using a high-sensitivity standard solution from Sigma. Insulin 
was measured by radioimmunoanalysis, using a species-specific rat antibody, and 
glucose spectrophotometrically in the Ligand and the Biochemistry Core Labora- 
tories, respectively, of the Diabetes Center of the University of Michigan Medical 
Center, Ann Arbor. 
Calculations: For calculations of apparent concentrations of amino acids in cell 
water, the liver and muscle samples were taken to contain, respectively, 49% and 
62% intracellular and 22% and 15% extracellular water (Christensen and Cullen, 
1981; Lowry and Hastings, 1942). The distribution ratio tissue/plasma was the ratio 
/~mol/kg cell water to #mol/kg extracellular water (Lowry and Hastings, 1942). 
Statistical analysis: Differences in plasma levels, intracellular concentrations and 
distribution ratios between rats treated with Leu, Leu and diazoxide, or aBCH, and 
control rats were calculated by the t-test using separate variances when the number 
of controls and treated animals differed (Wilkinson, 1986). 
RESULTS 
Plasma levels, net intracellular concentrations and distribution ratios of the amino 
acids studied after Leu administration, in the absence and in the presence of diazoxide 
are shown in Table 1. Measurements were made in all cases at 2 h after injection 
because Ile, an amino acid whose distribution is well known to be particularly 
sensitive to Leu, was found in preliminary experiments to be strongly decreased in 
plasma by that time (data not shown). 
Plasma levels as well as net intracellutar concentrations in both liver and muscle 
of Leu itself showed statistically significant increases after Leu injection. These 
increments in Leu levels were about 3-5 times higher in the presence of diazoxide. 
The distribution ratio muscle/plasma for Leu showed a statistically significant 
decrease in the absence of diazoxide; otherwise the distribution ratios for Leu 
appeared unaffected. 
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Table 1 Changes in relative concentrations and distribution of each of nine neutral amino acids 
produced after injecting Leu or Leu plus diazoxide into weaning rats 
Leu Leu ÷ diazoxide 



















473** 337** 270** 1525" 1621" 1467" 
0.77 0.58*** 1.16 0.97 
36* 101 34* 90 171 82 
2.68*** 0.96 1.74 0.93 
34* 118 34** 59 90 51 
3.99*** 1.15 1.67"** 0.76 
49** 132 56** 40** 101 43 
2.83*** 1.39 2.64*** 1.17 
43* 119 47** 45* 65 40* 
2.76** 1.19 1.75 1.06 
40* 132 70 47** - - 
3.57** 1.86 
51" 72 60** 66*** 63 70*** 
1.59 1.29 0.96 1.18 
48* 118 70 67 157 73 
2.51"** 1.69 2.14 1.07 
56** 84 89 59** 90 97 
1.53"** 1.61"** 1.29 1.53"* 
The three values in each column show for plasma, liver, and muscle, respectively, the percentage of the 
control value attained in 2 h for each of these tissues for the amino acid named in column 1. The number 
below the percentage value for each amino acid shows the calculated relative distribution ratio between 
the concentrations in the cellular and extracellular water, as described under Methods, for the indicated 
solid tissue. The number of animals varies from 6 to 7, both for control and experimental groups. Asterisks 
indicate the statistical significance of changes: *p < 0.001, **p < 0.01, ***p < 0.05 
W i t h o u t  except ion  every o ther  amino  acid  s tudied  showed a s ta t is t ical ly  significant 
decrease  in its p l a s m a  concen t ra t ion  after Leu injection.  On ly  in the case of the o ther  
two b ranched -cha in  amino  acids  Ile and  Val as well as of  P ro  was the decrease in 
p l a s m a  concen t ra t ion  preven ted  by  diazoxide.  Ile and  Val showed as well a s tat is t ical ly 
significant decrease in their  net  in t race l lu la r  concen t ra t ion  in muscle  tha t  was 
p reven ted  also by  the previous  in ject ion of diazoxide.  D i s t r i bu t ion  ra t ios  of Ile and  
Val were pe r tu rbed  in the liver, but  not  in muscle; the observed  s tat is t ical ly significant 
increase in l iver was no t  p reven ted  by diazoxide.  
The  a roma t i c  amino  acids Phe  and  Tyr  showed also a s tat is t ical ly significant 
decrease in their  net  in t race t lu lar  concen t ra t ions  in muscle,  no t  p reven ted  by diazoxide.  
D i s t r i bu t ion  ra t ios  for Phe,  Tyr  and  M e t  were also increased in liver but  p reven ted  
by  d iazoxide  only  in the case of  Tyr. Tissue Me t  co-e lu ted  with Cys in the exper iments  
with d iazoxide  and  hence could  no t  be measured.  
Ala  showed a s ta t is t ical ly  significant decrease in its net  in t race l lu la r  concen t ra t ion  
in muscle,  an  effect insensit ive to diazoxide.  P ro  and  Gly  showed a s tat is t ical ly 
significant increase in their  respective d i s t r ibu t ion  ra t ios  for l iver tha t  was p reven td  
by  diazoxide.  G ly  and  P r o  were, a m o n g  all o ther  amino  acids  s tudied (Leu of course 
excluded f rom considerat ion) ,  the only ones tha t  d id  no t  show a s tat is t ical ly significant 
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decrease in their net intracellular concentration in muscle. Gly, on the other hand, 
was the only amino acid that showed a statistically significant increase in its 
distribution ratio in muscle after Leu administration. This effect was insensitive to 
diazoxide. 
Experiments parallel to those with Leu were made with the system L analogue 
aBCH (Figure 1). This isomer of BCH was selected because it is not an insulin 
secretagogue (Tager and Christensen, 1971) and hence could serve to dissociate that 
action from the suspected direct effects on amino acid transport (Oxender and 
Christensen, 1963; Christensen, 1987). Gly was the only amino acid that showed a 
statistically significant decrease in plasma concentration after aBCH. The only 
statistically significant change found in liver after aBCH was a decrease in the net 
intracellular concentration of Gly (data not shown). On the other hand, aBCH caused 
in muscle a statistically significant increase in the distribution ratios of Ala and Gly, 
reproducing the same distinctive effect of Leu for the latter (Figure 1). 
The effect of Leu in the absence and in the presence of diazoxide on plasma glucose 
and insulin concentrations at different times is shown in Figure 2. As expected, Leu 
caused a decrease in the plasma concentration of glucose that was prevented by 
diazoxide (Figure 2A). The insulin/glucose ratio was increased by 345% of the control 
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Figure 1 Plasma levels, distribution ratios, tissue/plasma, and net intracellular concentrations 
for muscle of neutral amino acids after aBCH injection. Data are shown as percentage of 
controls. N varied from 7 to 13 animals for both controls and experimental groups 
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Figure 2 Time course of glucose concentration (A) and of insulin/glucose ratio (B) in plasma 
after Leu injection in the absence or in the presence of diazoxide (Dz). Each point represents 
the average for three animals 
DISCUSSION 
Conceivably, Leu may cause a decrease in the plasma concentration of other amino 
acids by promoting their utilization in tissues directly (Buse and Weigand, 1977) or 
through insulin (Fulks et al., 1975). Membrane transport effects have also been 
proposed (Eriksson et al., 1981; Nyhan et al., 1961) although they have received little 
attention. Insulin could also act by stimulating membrane transport (Shotwell et al., 
1983). 
Under our experimental conditions, the amino acids studied were likely to be 
exposed to an insulin effect, according to the time course of glucose and insulin 
concentration changes. Although the latter were modest (data not shown), it is 
accepted that insulin variations in plasma are more properly interpreted by measuring 
the glucose levels simultaneously (Young and Kavam, 1991). Accordingly, the sharp 
increase in the insulin/glucose ratio and its prevention by diazoxide points to an 
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insulin-releasing effect of Leu (Figure 2B). This is consistent with previous work that 
showed that Leu is a potent insulin secretagogue in the rat (Landgraf et al., 1974). 
Although a direct effect cannot be ruled out at this time, it is likely that the effects 
of diazoxide observed here are due to its well known inhibitory effect on insulin 
release (Wolff et al., 1968). 
The selective sensitivity of some of these amino acids to diazoxide is, in fact, 
consistent with insulin effects in humans. Fukagawa et aI. (1986), using the euglycaemic 
insulin clamp technique, showed that Ile and Pro were the most sensitive among 
several amino acids. Moreover, in the same work these authors found that Gly and 
Ala concentrations in plasma were unaffected by insulin, as was observed in the 
present study. Contrary to our findings, however, they found a statistically significant 
decrease in Phe and Tyr plasma concentrations after insulin infusion (Fukagawa et 
al., 1986). We believe that a possible insulin contribution to the decrease in the 
plasma concentrations of Phe and Tyr in the present study was masked by a stronger 
effect of Leu in the utilization of these two aromatic amino acids. This interpretation 
is consistent with the observed enhanced incorporation of [14C]Tyr into protein, 
promoted by Leu in isolated rat diaphragm (Buse and Weigand, 1977). The decrease 
of Ala in plasma, clearly insulin-independent in this study, can also be explained by 
a direct effect of Leu on the utilization of this amino acid in muscle, as could be the 
case for Met also. 
Eriksson et aL (1981) found a small but statistically significant increase and decrease 
in plasma insulin and glucose concentrations, respectively, after Leu infusion to 
healthy human adults. Concomitantly these authors found a statistically significant 
decrease in the plasma levels of all the amino acids studied here, among others. 
However, they raised the possibility of stimulated exchange diffusion of the intracellu- 
lar Leu with the plasma large neutral amino acids through transport system L 
(Eriksson et al., 1981). Since we were particularly interested in net changes in amino 
acid distribution, our experimental design here does not allow us to exclude such a 
mechanism of stimulated exchange diffusion, which may be a very early event after 
Leu administration. In the present study, Gly was the only amino acid that showed 
a statistically significant increase in its distribution ratio muscle/plasma (Table 1). 
The parallel finding that only Gly showed a statistically significant decrease and 
increase, respectively, in its plasma concentration and in its distribution ratio 
muscle/plasma after aBCH administration (Figure 1) strongly suggests that the 
corresponding decrease of Gly in plasma caused by Leu is due to trapping of this 
amino acid by inhibition of its exodus from muscle cells through system L, according 
to the hypothesis proposed here. This explanation is again consistent with early and 
recent work in our laboratory showing that Gly, Ala and Pro seem particularly 
prone to be trapped into muscle and liver cells in the presence of excesses of Phe (de 
C6spedes et al., 1989, their figs. 3 and 4) and other system L substrates or analogues 
(Christensen et aL, 1948). This effect probably arises at least in part from the readiness 
of the entry of the small neutral amino acids through Na +-dependent system A, a 
movement parallel, but in the opposite direction, to the one occurring through system 
L in muscle and liver (Christensen, 1987; de C6spedes et al., 1989). Accordingly, the 
statistically significant decrease in Pro plasma concentration may be explained by 
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transport effects as shown by the statistically significant increase in its distribution 
ratio liver/plasma. Since the distribution ratio liver/plasma for Gly also showed a 
statistically significant increase, its trapping in liver may make an additional 
contribution to its decrease in plasma. Moreover, this apparent enhancement of 
transport of Pro and Gly in liver is not observed in the presence of diazoxide. Since 
transport system A has been shown to be responsive to insulin in isolated preparations 
of liver and muscle (Shotwell et al., 1983), a role for insulin in stimulating the entry 
of Pro and Gly through system A in liver seems likely. Although not statistically 
significant, the increase in the distribution ratio liver/plasma, and its relative decrease 
in the presence of diazoxide, is also observed for Ala. 
We have no explanation at this time for the mechanism of the increased distribution 
ratios liver/plasma for Ile, Val, Phe, Tyr and Met that otherwise is probably 
contributing to the depletion of these amino acids in plasma. We do not know either 
why these increases, with the exception of Tyr, are all unaffected by diazoxide. 
A stimulatory effect of the enzymes of the branched-chain amino acid catabolic 
pathways has been proposed as a mechanism of the Leu-induced decrease in the 
plasma concentrations of Ile and Val (Phansalker et al., 1970). If this mechanism 
were to operate in MSUD, some residual stimulative activity of the branched-chain 
ketoacid decarboxylase should still be present. Insulin levels have been reported as 
normal in patients with MSUD (Soltesz et al., 1983). Since in the present study, the 
observed Leu-induced decrease of Ile and Val in plasma and muscle was prevented 
by diazoxide, insulin seems to play a role in this effect, at least under our experimental 
conditions. Utilization of Leu itself in liver and muscle, probably for protein synthesis 
(Tessari et al., 1987), is apparently enhanced by insulin, since much higher levels were 
observed in those tissues as well as in plasma in the presence of diazoxide. 
Distinguishing among the above mechanisms may be important in guiding attempts 
to correct amino acid imbalances in hereditary or acquired disease states that may 
lead to short- or long-term deleterious effects, especially on the brain. We have 
discussed this subject (Christensen, 1987; de C6spedes et aI., 1989). A compensation 
for such effects might be attained by the administration of selected amino acids or 
amino acid analogues, or of insulin or insulin antagonists. Further work is needed, 
however, to assess the significance of the depletion of plasma neutral amino acids, 
some of them (such as Phe and Tyr) precursors of neurotransmitters or themselves 
neurotransmitters as is Gly, as a cause of impairment of the function or the structure 
of the brain. 
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SHORT REPORT 
Alloisoleucine in isovaleric acidaemia 
D. Rabier l, P. Parry 1, J. Bardet 1, J. M. Saudubray 2 and P. Kamoun 1 
L-Alloisoleucine (L-aIle) is the isomer of the protein amino acid L-isoleucine (L-Ile). 
This non-protein amino acid has been reported in high concentrations in the plasma 
of patients with branched-chain ketoacid (BCKA) dehydrogenase deficiency (maple 
syrup urine disease) or of patients receiving a diet supplemented with BCKA. In this 
paper we report  the presence of L-aIle in the plasma of three patients with isovaleric 
acidaemia (IVA) (McKusick 24350). 
These patients, D.A., R.P. and R.A., were 27, 13 and 13 months old respectively; 
R.P. and R.A. are twins. They were diagnosed during the first week of life by gas 
chromatography-mass spectrometry. These children received a protein-restricted diet 
during the first 6 months of life and then a normal diet. This diet was supplemented 
by a mixture of amino acids lacking L-Leu (from 15 days to 18 months for D,A. and 
between 15 and 20 days of age for R.P. and R.A.). All the patients received glycine 
(250 mg k g - i  day-1)  and L-carnitine (100-200 mg kg-1 day- i ) .  Their plasma amino 
acids are regularly controlled by ion-exchange chromatography (Beckman 6300 
System). The mixture of amino acids used as nitrogen supplementation was checked 
for the absence of L-Leu and L-aIle. For  these three patients L-aIle was undetectable 
during the first 2 weeks of life. After this time L-aIle ranged from 2 to 10#mol/L 
(controls undetectable). When L-aIle was undetectable, L-Ile concentration was very 
low (range 18-28/~mol/L; control mean __ SD 64 +__ 15 and range 35- 101, n = 174). 
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